Learn More
                                    Selleck Chemical LLC LTI-291 S1024-100mg
                                    
                                    
                                    
                                    
                                
                            
                            
                            
                            
Supplier: Selleck Chemical LLC S1024100MG
            LTI-291 is the first small-molecule activator of Glucocerebrosidase(GCase) for the treatment of parkinson s disease
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.